Tag: the war on (some) drugs

The wild psychedelic origins of indigenous mystical rites — as revealed by archaeology

We’ll never know when and where humans first discovered the mind-altering power of psychedelics. But it seems fair to state three things about our relationship with visionary drugs: it’s incalculably old, globally pervasive, and rich with meaning. Our ancestors likely began their long journey with naturally occurring psychotropic substances tens or even hundreds of thousands of years ago.

The nascent field of archaeochemistry has convincingly demonstrated Neanderthal use of psychoactive plants like yarrow and chamomile going back 50,000 years. Anthropologist Scott M. Fitzpatrick envisions the early hunter-gatherers of our own species encountering, consuming and experimenting “with a wide array of plants” and fungi — just like their Neanderthal cousins.

A generation ago, Terence McKenna famously introduced the Stoned Ape Theory, proposing an evolutionary advantage for a diet of psilocybin-containing mushrooms across the African savannas — not merely hundreds of thousands, but millions of years in our hominin past, prompting the development of proto-language, creativity, and religious insight well before the Neanderthals. Only now are scholars, like paleoanthropologist Lee Berger in South Africa, seriously investigating the bold claim.

Keep reading

Political Stupidity and Bureaucratic Bungling Created New York’s Pot Legalization ‘Disaster’

As of last June, more than two years after New York legalized recreational marijuana, just 12 state-licensed dispensaries had opened for business, falling far short of Gov. Kathy Hochul’s prediction that more than 100 would be operating by that summer. Six months later, Hochul was bragging that “nearly 40 adult-use dispensaries will have opened in 2023.” The current count is 87. Those stores, The New York Times notes, “are far outnumbered by more than 2,000 rogue head shops, the target of complaints that they siphon customers, sell to children and attract criminals.”

New York’s rollout of marijuana legalization has been a “disaster,” as Hochul conceded in January. “Every other storefront” is an unlicensed pot shop, she told The Buffalo News. “It’s insane.”

That disaster has frustrated would-be retailers, left farmers in the lurch, played havoc with tax revenue projections, and made a joke out of any expectation that New York, by learning from the experience of states that legalized marijuana earlier, would do a better job of displacing the black market. The insanity that Hochul perceives is a product of bad decisions by politicians who should have known better and obstruction by regulators who sacrificed efficiency on the altar of diversity.

Unlike states such as New Jersey, where voters approved legalization in 2020, and Maryland, where a similar ballot initiative passed two years later, New York did not initially allow existing medical dispensaries to start serving the recreational market. Its slow and complicated licensing process, which was skewed by an “equity” program that prioritized approval of applicants with marijuana-related criminal records or their relatives, is maddeningly hard to navigate.

Those preferences invited lawsuits by people who were excluded, which further delayed approval of licenses. Guidance and financial help for people struggling to jump through the state’s hoops never materialized. And as in other states, high taxes and burdensome regulations have made it hard for licensed businesses to compete with unauthorized dealers.

Keep reading

Nebraska Lawmakers Approve 100% Tax Rate For CBD And Hemp Products To Help Offset Property Taxes

A Nebraska legislative committee has given preliminary approval to a bill that would tax hemp and CBD products in the state at a whopping 100 percent rate.

The cannabis product tax hike is part of legislation designed to bring in more money to state coffers to offset property tax bills, according to an outline of the plan from Sen. Lou Ann Linehan (R), the legislation’s sponsor, that was posted by a Nebraska Public Media reporter.

The legislature’s Revenue Committee advanced the underlying measure, LB 388, on a 7–0 vote on Thursday, according to a report in the Nebraska Examiner. The state’s full unicameral legislature could take up the bill as soon as Tuesday.

“We are going to tax hemp and CBD at 100%,” Linehan’s document says, adding that, along with other reforms—including removing sales tax exemptions on soda, candy, pet services, advertising revenue over $1 billion and lottery tickets—the change is estimated to bring in $182 million in new revenue for the state.

The changes are not currently reflected in the bill’s language as available online, nor has any relevant amendment been posted to the bill page. Linehan, who also chairs the panel that approved the measure this week, did not immediately respond to emailed questions from Marijuana Moment.

Adam Morfeld, a former Nebraska state senator who co-chairs the advocacy group Nebraskans for Medical Marijuana, reacted to the proposal with shock.

“The Legislature is going to tax hemp and CBD at 100 percent!??” he posted on social media.

Keep reading

Organ Donations From Marijuana Users Pose No Significant Infectious Risks, Study Finds

A new federally funded study examining the possible risks of organ donation by marijuana users found no indication that recent cannabis use increases the likelihood of significant side effects in the year immediately after a transplant—even as many healthcare providers continue to restrict transplants to cannabis consumers.

Findings of the research, which looked at rates of infections, transplant failures and deaths among recipients, “suggest that organs from donors with a history of recent marijuana use do not pose significant infectious risks in the early posttransplant period.”

“Despite concern that donor exposure to marijuana increases the risk of fungal infection in recipients, our study found that a donor history of marijuana use did not increase (1) the likelihood of donor culture positivity (including respiratory cultures), or (2) the risk of early recipient bacterial or fungal infection, graft failure, or death posttransplant,” authors wrote. “Even when evaluating only lung recipients, there remained no association between donor marijuana use and the risk of posttransplant infection.”

As more states have legalized marijuana, reported rates of use among adults have also risen, notes the new study, published late last month in the American Journal of Transplantation. “It is likely that a growing proportion of deceased organ donors have a history of marijuana use, as well,” it says, “though this metric has not been specifically reported.”

Keep reading

Study Finds Natural Psychedelic Mushrooms Produce ‘Enhanced Effects’ Compared To Synthesized Psilocybin, Suggesting Entourage Effect

A new study suggests that the use of full-spectrum psychedelic mushroom extract has a more powerful effect than chemically synthesized psilocybin alone, which could have implications for psychedelic-assisted therapy. The findings imply that the experience of entheogenic mushrooms may involve a so-called “entourage effect” similar to what’s observed with cannabis and its many components.

“To date, clinical trials have generally been conducted with chemically synthesized psilocybin,” wrote the 15-person research team, representing institutions such as the Hadassah Medical Center at Hebrew University in Jerusalem, Boston-based Human Metabolome Technologies, Parow Entheobiosciences in Chicago and others, “and little attention has been given to additional, potentially therapeutic, psychoactive or non-psychoactive compounds found in psychedelic mushrooms.”

The findings, they said, indicate full-spectrum psychedelic mushroom extract (PME) “has a more potent and prolonged effect on synaptic plasticity” than chemically synthesized psilocybin (PSIL) on its own.

“These findings open up new possibilities for the therapeutic use of natural psychedelic compounds, providing hope for those who have found little relief in conventional psychiatric treatments,” Hebrew University said in a press release, adding that the study “suggests that psilocybin-containing mushroom extract may offer unique therapeutic effects not achievable with psilocybin alone.”

“This research not only underscores the superiority of extracts with diverse compounds,” the release says, “but also highlights the feasibility of incorporating them into Western medicine.”

To conduct the study, published late last month in the journal Molecular Psychology, researchers injected adult male mice with either synthesized psilocybin or a full-spectrum mushroom extract that contained not only psilocybin but also psilocin, norpsilocin, baeocystin, norbaeocystin and aerugeniscin. They then examined behavior in the mice, such as a head-twitch response (HTR), as well as samples of dissected brain tissue. Effects were measured at three days and 11 days after treatment.

“Our findings show no difference in acute effects on HTR,” authors wrote. “However, we found an effect of PME on synaptic protein levels in 4 brain areas that is significantly more pronounced overall than the effect of PSIL.”

Those synaptic proteins, they said, are seen as possible markers of neuroplasticity, which they describe as “the lifelong capacity of the brain to respond to experiences, learning and the environment and to reorganize structure, function and connections in response to such stimuli.”

That effect is believed to be central to the function of psychedelics in therapy.

Keep reading

Legalizing Marijuana For Adults Does Not Drive Increases In Youth Use, New Federally Funded Study Finds

New federally funded research into the impacts of marijuana legalization on youth use found no association between legal adult-use cannabis sales and the prevalence of consumption among middle-school students.

To test whether legal sales led to an uptick in youth use, authors compared middle-school use rates in Nevada and New Mexico, looking at 2017 and 2019 data from two state-run surveys. At the time, adult-use marijuana sales were legal in Nevada, while New Mexico allowed only medical marijuana.

In both states, researchers found increases in the proportions of students that had ever consumed cannabis as well as those who had consumed within the past 30 days.

In Nevada, the share of middle-school students who said they’d ever consumed cannabis rose during the study period, from 9.7 percent in 2017 to 13.3 percent in 2019. Past 30 day (P30D) use also rose, from 6.3 percent to 8.9 percent.

New Mexico, where recreational marijuana remained illegal, saw lifetime use rise from 14.1 percent to 17.4 percent over the same period. Past 30 day use rose from 8.9 percent to 10.5 percent.

Keep reading

Colorado Bill Would Force Social Media Platforms To Ban Users Who ‘Promote’ Marijuana, Psychedelics And Hemp Products

A center-right think tank is raising alarm about a Colorado bill that it says would make it illegal to talk positively about marijuana online. The prohibition would also apply to many hemp products as well as some federally legal pharmaceuticals.

Among other provisions, SB24-158—a broad proposal around internet age verification and content policies—would require social media platforms to immediately remove any user “who promotes, sells, or advertises an illicit substance.”

The bill’s definition of illicit substance includes not only illegal drugs but also many that are legal and regulated in Colorado. It pertains to any controlled substance under state law, including schedules I through V under state law.  That means the bill would affect state-legal marijuana, certain psychedelics—which voters legalized through a 2022 ballot measure—and even some over-the-counter cough syrups that contain small amounts of codeine.

Beyond scheduled drugs, the bill specifies that its restrictions also apply to certain hemp products with more than 1.25 milligrams THC or a CBD-to-THC ratio of less than 20 to 1 and most other hemp-containing products intended for human consumption.

If enacted onto law, companies would also need to publish “a statement that the use of the social media platform for the promotion, sale, or advertisement of any illicit substance…is prohibited.”

The R Street Institute says the restriction would impact not only cannabis companies but also any individual who posts positively about marijuana.

“Basically, the Colorado Legislature is trying to force social media companies to ban the promotion of marijuana,” the group’s social media director, Shoshanna Weissman, wrote in a new article. “And because what constitutes ‘promotion’ remains undefined, the bill would likely force platforms to remove all pro-marijuana free speech in a state where recreational use is legal.”

Not only is the ambiguity of “promotion” an issue, but the bill’s broad definition of illicit substances could also cause confusion, R Street says.

The think tank points out that the bill’s definition of illicit substances “would make it unlawful for businesses to promote them for sale or even for regular people to talk about their benefits online.”

“This clearly violates the First Amendment, as the bill is unconstitutionally narrow in scope,” Weissman wrote. “Basically, if speaking highly of or advertising these substances were truly dangerous, the state would have banned advertising in all its forms (e.g., print, television, digital).”

Keep reading

Federal Marijuana Prohibition Has ‘No Rational Basis,’ Companies Say In New Court Filing

In a new federal court filing, lawyers for a group of marijuana companies argue that ongoing broad cannabis prohibition has “no rational basis,” pointing to the government’s largely hands-off approach to the recent groundswell of state-level legalization.

The lawsuit alleges that while Congress’s original intent in banning marijuana through the Controlled Substances Act (CSA) was to eradicate illicit interstate commerce, lawmakers and the executive branch have since abandoned that mission as more states have moved to regulate the drug.

“Dozens of states have implemented programs to legalize and regulate medical or adult use marijuana,” the new filing from the plaintiffs in the case says. And by providing consumers with “safe, regulated, and local access to marijuana,” those states “have reduced illicit interstate commerce, as customers switch to purchasing state-regulated marijuana over illicit interstate marijuana.”

The new 32-page document comes in response to the government’s effort in January to dismiss the cannabis companies’ underlying suit. At the center of the case is a 2005 Supreme Court decision, Gonzales v. Raich, in which justices held that federal prohibition preempts state-level legalization because of Congress’s interest in preventing illegal marijuana from entering interstate commerce.

Plaintiffs argue that given the changes since then—not only at the state level, but also in terms of the government’s own tolerance of commercial cannabis activity in legal jurisdictions—”the federal government no longer has any basis for insisting that state-regulated, intrastate marijuana must be banned to serve Congress’s interstate goals.”

“The ground-shaking shifts in marijuana regulation since Raich, together with the nation’s long history of marijuana cultivation and use prior to the CSA,” lawyers wrote in the new filing, “demonstrate the widely-held understanding that Plaintiffs’ marijuana activities implicate a liberty interest that requires protection.”

In the overarching lawsuit, filed in October, the businesses behind the case claim that perpetuating marijuana prohibition in state markets is unconstitutional, creating undue public safety risks while precluding licensed cannabis operators from accessing critical financial services and tax deductions that are available to other industries.

Keep reading

ATF Agent Stops Gun Sale Over Marijuana Odor And DOJ Argues Cannabis Consumers Don’t Have 2nd Amendment Rights 

Second Amendment advocates are criticizing a pair of recent developments around marijuana and firearms—issues they say underscore the need for further reform.

Last month during a routine audit of a gun dealer, a federal Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) investigator reportedly ordered the store to stop the sale of a pistol because the investigator claimed the would-be buyer smelled of marijuana.

“I wasn’t high,” the prospective buyer told the Second Amendment Foundation, according to the outlet Ammoland, which referred to the individual only as Daniel. “None of this makes any sense to me.”

Daniel had already filed federal paperwork saying he was eligible to own a firearm and had passed a background check for the handgun, according to the report. When he went to pick it up at a Plant City, Florida store, however, the ATF industry operations investigator reportedly halted the sale.

ATF spokesman Jason Medina acknowledged that the smell of marijuana could have been from exposure to second-hand smoke and not an indication that the gun buyer himself had consumed cannabis.

“That’s true,” Medina told Ammoland.

Meanwhile in a federal appeals court case, the Department of Justice argued in a filing earlier this month that marijuana users “are more likely than ordinary citizens to misuse firearms,” likening them to “the mentally ill” as well as “infants, idiots, lunatics, and felons.”

Keep reading

Morocco celebrates huge cannabis harvest – legally for the first time

Morocco’s first legal cannabis harvest was 294 metric tons in 2023, after the country approved its cultivation and export for medicine and industrial uses, the cannabis regulator has said said.

The harvest was made by 32 cooperatives that brought together 430 farmers covering 277 hectares in the northern Rif mountain areas of Al Houceima, Taounat and Chefchaouen, ANRAC claimed.

The United Nations drugs agency says about 47,000 hectares of the Rif are devoted to cannabis output, roughly a third of the amount in 2003 after government crackdowns.

This year, the regulator is examining applications by 1,500 farmers who organised themselves into 130 cooperatives, ANRAC said.

Cultivation of the local drought-enduring landrace, known as Beldia, began this month, it said.

Although Morocco is a major cannabis producer, officially cannabis use for recreational purposes is illegal. In practice, it is tolerated.

Nearly a million people live in areas of northern Morocco where cannabis is the main economic activity. It has been publicly grown and smoked there for generations, mixed with tobacco in traditional long-stemmed pipes with clay bowls.

The legalisation was intended to improve farmers’ incomes and protect them from drug traffickers who dominate the cannabis trade and export it illegally.

So far, two legal cannabis transformation units have been operating and two others are waiting for equipment, while 15 cannabis products are in the process of being authorised for medicinal use, ANRAC said.

Morocco is also seeking to tap into a growing global market for legal cannabis, and awarded 54 export permits last year.

Keep reading